Pharmacogenetics explores heritable genetic polymorphisms that can effect responses to drug therapy. Many studies have focused on several genetic polymorphisms, which are involved in cholesterol metabolism, trying to define their contribution to a potential genotype-guided treatment against dyslipidemia adult.